Annual Mortgage Lending Up at Prosperity

Even though quarterly originations moved lower at Prosperity Home Mortgage LLC, an up tick was recorded for annual activity.

As of Dec. 31, 2016, the Chantilly, Virginia-based firm carried 443 employees on its payroll, 10 more than three months earlier.

Those details and more were provided as part of the Mortgage Daily Fourth Quarter 2016 Mortgage Origination Survey.


…read more

From:: Financing

Mortgage LOS Improvements, Integrations

One of the industry’s most popular loan origination systems has been upgraded. Other LOS enhancements involve technology integrations.

Ellie Mae Inc.’s all-in-one mortgage management platform, Encompass, has been upgraded to version 17.1, a news release Monday said.

This iteration of the LOS includes expanded support for construction loans and more streamlined workflow integrations with Fannie Mae and Freddie Mac.


…read more

From:: Financing

Mortgage LOS Improvements, Integrations

One of the industry’s most popular loan origination systems has been upgraded. Other LOS enhancements involve technology integrations.

Ellie Mae Inc.’s all-in-one mortgage management platform, Encompass, has been upgraded to version 17.1, a news release Monday said.

This iteration of the LOS includes expanded support for construction loans and more streamlined workflow integrations with Fannie Mae and Freddie Mac.


…read more

From:: Financing

A private mortgage insurer’s view on the FHA mortgage insurance premium suspension

When the Department of Housing and Urban Development announced it suspended the reduction of FHA mortgage insurance premiums, it helped the private mortgage insurance market retain $10 billion in volume. Duane Duncan, head of Government relations at Genworth, gave an inside perspective of how the move impacts the private sector, whether it’s reenacted or forever off the table. …read more

From:: Real Estate Wire

PayPal shares slip on subpoenas in money-laundering probe

PayPal Holdings Inc. shares declined in the extended session Wednesday after the payment-services company said it received a subpoena from the Department of Justice over a money-laundering probe. PayPal shares fell 2.2% to $39.99 after hours. In a filing with the Securities and Exchange Commission late Wednesday, the company said it received subpoenas “seeking the production of certain information related to our historical anti-money laundering program.” PayPal said it is cooperating with the investigation and that it is unable to predict the government’s response.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Zendesk shares rise after narrower-than-expected loss

Zendesk Inc. shares rose in the extended session Wednesday after the enterprise software company reported a narrower-than-expected loss for the quarter. Zendesk shares rose 6% to $26.01 after hours. The company reported an adjusted fourth-quarter loss of 4 cents a share on revenue of $88.6 million. Analysts surveyed by FactSet had forecast a loss of 6 cents a share on revenue of $87.3 million. Zendesk expects an adjusted first-quarter loss between $6 million and $7 million on revenue of $91 million and $93 million. Analysts expects a loss of $5.4 million on revenue of $91.9 million.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Federal appeals court decision will keep Regeneron/Sanofi drug at center of patent dispute on market, for now

A federal appeals court temporarily stopped another judge’s decision that would have forced Regeneron and Sanofi to stop selling cholesterol drug Praluent. The Tuesday decision, though expected, “means that Praluent will not come off the market by Feb. 21,” and could even stay on the market through the rest of the year, said Evercore ISI analyst Mark Schoenebaum. The previous judge’s decision in favor of Amgen Inc. was a key victory for Amgen, and sent its shares up on Jan. 7, the day the decision emerged. Praluent and Amgen’s drug Repatha are part of an expensive class of drugs that cost upward of $14,000 a year. Regeneron shares, which were halted on the news, have slumped 4.0% over the last three months, compared with a 7.3% rise in the S&P 500 .

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Roomba maker iRobot shares fall 9% after earnings

iRobot Corp. shares fell late Wednesday despite an earnings and sales beat for the maker of Roomba, the robotic vacuum cleaner. iRobot said it earned $13.7 million, or 49 cents a share, in the fourth quarter, compared with $19.3 million, or 65 cents a share, in the year-ago period. Sales reached $212.5 million, compared with $206.4 million a year ago. Analysts polled by FactSet expected iRobot to report earnings of 41 cents a share on sales of $206 million. The company said it was expecting revenue of $770 million to $785 million this year. Shares ended the regular trading session down 1.1%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News